Abstract
The aims of this study were to identify the presence of endothelial dysfunction as a marker of early atherosclerosis by measuring aortic and carotid intimal-medial thickness (aIMT and cIMT) and flow-mediated dilation (FMD) and their correlation with traditional and no traditional risk factors for atherosclerosis in children with rheumatic diseases. Thirty-nine patients (mean age 15.3 ± 5.7 years), 23 juvenile idiopathic arthritis, 9 juvenile spondyloarthropathies, 7 connective tissue diseases (mean disease duration and onset respectively 5 ± 3.6 and 10 ± 5 years), and 52 healthy children matched for sex and age were enrolled. Demographic data (age, sex, familiarity for cardiovascular disease), traditional risk factors for atherosclerosis (BMI, active and passive smoking, dyslipidemia), activity disease indexes (reactive count protein, erythrocyte sedimentation rate) autoantibodies, and complement tests were collected. aIMT, cIMT, and FMD were assessed following a standardized protocol by high-resolution ultrasonography. Patients resulted significantly more exposed to passive smoking and had a lower BMI and higher homocysteine level than controls. cIMT and aIMT were significantly higher in patients than controls (p < 0.001) and correlated with age at diagnosis (p < 0.001 r 0.516 and 0.706, respectively) but not with mean disease duration. FMD % was significantly reduced in patients compared to controls (p < 0.001). Subclinical atherosclerosis occurs in pediatric rheumatic diseases, mainly in early onset forms, and aIMT is an earlier marker of preclinical atherosclerosis. Premature endothelial dysfunction could be included in the follow-up of children with rheumatic disorders to plan prevention strategies of cardiovascular disease already in pediatrics.
Similar content being viewed by others
References
WHO (2014) Global health estimates: death by cause, age, sex and country, 2000–2012. WHO, Geneva
Hong YM (2010) Atherosclerotic cardiovascular disease beginning in childhood. Korean Circ J 40:1–9. doi:10.4070/kcj.2010.40.1.1
Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2006) Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol 24:115–117
Satija M, Yadav TP, Sachdev N et al (2014) Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis. Clin Exp Rheumatol 32:432–439
Vincze M, Dér H, Kerekes G et al (2014) Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients. Clin Rheumatol 33:1635–1641. doi:10.1007/s10067-014-2561-y
Hollan I, Meroni PL, Ahearn JM et al (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun rev 12:1004–1015. doi:10.1016/j.autrev.2013.03.013
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392
Gmuca S, Weiss PF (2015) Juvenile spondyloarthritis. Curr Opin Rheumatol 27:364–372. doi:10.1097/BOR.0000000000000185
Petty R, Laxer R, Lindsey C, Wedderburn L (2016) Textbook of pediatric rheumatology
Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146:483–494. doi:10.1093/oxfordjournals.aje.a009302
Berni A, Giuliani A, Tartaglia F et al (2011) Effect of vascular risk factors on increase in carotid and femoral intima-media thickness. Identification of a Risk Scale. Atherosclerosis 216:109–114. doi:10.1016/j.atherosclerosis.2011.01.034
Hennerici M, Meairs S (2000) Imaging arterial wall disease. Cerebrovasc Dis 10:9–20
Davis PH, Dawson JD, Blecha MB et al (2010) Measurement of aortic intimal-medial thickness in adolescents and young adults. Ultrasound med Biol 36:560–565. doi:10.1016/j.ultrasmedbio.2010.01.002
Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task force. J am Coll Cardiol 39:257–265
Stojan G, Petri M (2013) Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol 62:255–262. doi:10.1097/FJC.0b013e31829dd857
Mahajan V, Handa R, Kumar U et al (2008) Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J Assoc Physicians India 56:587–590
Vlahos AP, Theocharis P, Bechlioulis A et al (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63:1736–1744. doi:10.1002/acr.20613
Evensen K, Aulie HA, Rønning OM et al (2016) Carotid atherosclerosis in adult patients with persistently active juvenile idiopathic arthritis compared with healthy controls carotid atherosclerosis in adult patients with persistently active juvenile idiopathic arthritis compared with healthy controls. J Rheumatol. 43(4):810–5. https://doi.org/10.3899/jrheum.150499
Breda L, Di Marzio D, Giannini C et al (2013) Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis. Clin Res Cardiol 102:63–71. doi:10.1007/s00392-012-0496-3
Pietrewicz E, Urban M (2007) Early atherosclerosis changes in children with juvenile idiopathic arthritis. Pol Merkur Lek 22:211–214
Soltész P, Dér H, Kerekes G (2009) A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases. Clin Rheumatol 28:655–662. doi:10.1007/s10067-009-1118-y
Urbina EM, Williams RV, Alpert BS et al (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the american heart association. Hypertension 54:919–950. doi:10.1161/HYPERTENSIONAHA.109.192639
Lim TK, Lim E, Dwivedi G, Kooner J, Senior R (2008) Normal value of carotid intima-media thickness—a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J am Soc Echocardiogr 21:112–116
Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658–666. doi:10.1002/art.24516
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med Apr 21:1685–1695
Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862–873
Van Halm VP, Nurmohamed MT, Twisk JW et al (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151. doi:10.1186/ar2045
Dixon WG, Watson KD, Lunt M et al (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905–2912. doi:10.1002/art.22809
Westlake SL, Colebatch AN, Baird J et al (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 49:295–307. doi:10.1093/rheumatology/kep366
Choi HK, Hernán MA, Seeger JD et al (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173–1177. doi:10.1016/S0140-6736(02)08213-2
Guin A, Chatterjee Adhikari M, Chakraborty S et al (2013) Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study. Semin Arthritis Rheum 43:48–54. doi:10.1016/j.semarthrit.2012.12.027
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
A written informed consent was given and signed by the parents or caregivers (and from the patients ages >16 years) after detailed information on the nature of the procedures. This study was approved by the hospital ethics committee.
Funding
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this manuscript.
Disclosures
None.
Additional information
Key messages
• Chronic inflammation appears to play a role in the development of atherosclerosis in rheumatic diseases.
• Subclinical atherosclerosis occurs in pediatric rheumatic diseases and aIMT might be an earlier marker.
Rights and permissions
About this article
Cite this article
Del Giudice, E., Dilillo, A., Tromba, L. et al. Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases. Clin Rheumatol 37, 1675–1682 (2018). https://doi.org/10.1007/s10067-017-3705-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3705-7